Zobrazeno 1 - 10
of 184
pro vyhledávání: '"C. Endresen"'
Autor:
Vesa Anttila, Petter C Endresen, Thor Trovik, Lone Juul Hune Mogensen, Mitchell Lindsay, Niels Ramsing Holm, Alastair N J Graham, Leif Thuesen, Terje K. Steigen, Indulis Kumsars, Timo H. Mäkikallio, Thomas Kellerth, Ian B. A. Menown, Evald Høj Christiansen, Rikard Linder, Noble study investigators, Per Hostrup Nielsen, Andrejs Erglis, David Hildick-Smith, Truls Myrmel, Mark S. Spence, Giedrius Davidavicius
Publikováno v:
Steigen, T, Holm, N R, Myrmel, T, Endresen, P C, Trovik, T, Mäkikallio, T, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Kumsars, I, Kellerth, T, Davidavičius, G, Linder, R, Anttila, V, Juul Hune Mogensen, L, Hostrup Nielsen, P, Graham, A N J, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2021, ' Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis : A NOBLE Trial Substudy ', Cardiology, vol. 146, no. 4, pp. 409-418 . https://doi.org/10.1159/000515376
Background: In the treatment of left main coronary artery (LMCA) disease, patients’ age may affect the clinical outcome after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). This study stratified the clinical out
Publikováno v:
Plastic and Reconstructive Surgery Global Open
Summary: A bronchopleural fistula (BF) is a life-threatening complication. Optimal management of a BF is still debated although surgery remains the preferred treatment. Usually, the fistula is a result of inadequate healing at the bronchial stump aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddad862e26ddf40b4dd7670d07e84277
https://hdl.handle.net/10037/17260
https://hdl.handle.net/10037/17260
Autor:
Petter C Endresen, Sven M. Almdahl
Publikováno v:
The Annals of Thoracic Surgery. 107:325
Autor:
Jan Ravkilde, Thor Trovik, Rikard Linder, Keith G. Oldroyd, Juha Hartikainen, Gintaras Kalinauskas, Niels Ramsing Holm, Leif Thuesen, Evald Høj Christiansen, Thomas Kellerth, Michael Maeng, Peteris Stradins, Hannu Romppanen, Mark S. Spence, Terje K. Steigen, Ole Fröbert, Markku O. Pentikäinen, Colm G. Hanratty, Matti Niemelä, Vesa Anttila, Indulis Kumsars, Per Hostrup Nielsen, Ian B. A. Menown, Uday Trivedi, Olli A. Kajander, Erlend Eriksen, Jens Flensted Lassen, Mitchell Lindsay, Timo H. Mäkikallio, Adrian P. Banning, Kari Kervinen, Lisette Okkels Jensen, Sulev Margus, Petter C Endresen, Azfar Zaman, Simon J Walsh, Markku Eskola, Matthias Corbascio, Henrik Toft Sørensen, Jamen Cotton, Andrejs Erglis, Alastair N J Graham, Anders Hervold, David Hildick-Smith, Geoff Berg
Publikováno v:
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', The Lancet, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Corbascio, M, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet, vol. 388, no. 10061, pp. 2743–2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Berg, G & for the NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet Oncology, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/s0140-6736(16)32052-9
Mäkikallio, T, Holm, N R, Lindsay, M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, L O, Kalinauskas, G, Linder, R B A, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, H T, Nielsen, P H, Niemelä, M, Kervinen, K, Lassen, J F, Maeng, M, Oldroyd, K, Berg, G, Walsh, S J, Hanratty, C G, Kumsars, I, Stradins, P, Steigen, T K, Fröbert, O, Graham, A N J, Endresen, P C, Corbascio, M, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet, vol. 388, no. 10061, pp. 2743–2752 . https://doi.org/10.1016/S0140-6736(16)32052-9
Berg, G & for the NOBLE study investigators 2016, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE) : a prospective, randomised, open-label, non-inferiority trial ', Lancet Oncology, vol. 388, no. 10061, pp. 2743-2752 . https://doi.org/10.1016/s0140-6736(16)32052-9
BACKGROUND: Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main coronary artery disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing. We aimed to
Autor:
Arne Grov, C. Endresen
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Section B Microbiology. :305-308
The teichoic acid of polysaccharide P (poly P) contains glycerol, glucose and phosphate. Hydrofluoric acid and alkali hydrolysates contain glycerol 1-phosphate, glycerol diphosphate, and glucose 1-phosphate, but no glucosyl-glycerol fragments. Glucos
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Signe Gilen, Lena C Endresen
Publikováno v:
Development. 43:29-33
Lena C. Endresen and Signe Gilen illustrate how in the Interim Agreement of 1995, Israel and the PLO agreed to cooperate on a people-to-people programme in accordance with concepts developed together with Norway. The Israeli-Palestinian People-to-Peo
Autor:
D.N McMillan, Christopher J. Secombes, S.H Hamdani, C Endresen, Heidrun I. Wergeland, A.E Ellis, Eirin Fausa Pettersen
Publikováno v:
Veterinary Immunology and Immunopathology. 63:369-380
A magnetic cell sorting system has been optimised for the purification of rainbow trout neutrophils using a monoclonal antibody (E3D9) raised against Atlantic salmon neutrophils. The purified neutrophils have good viability (85%) and purity (approxim
Publikováno v:
Scandinavian Cardiovascular Journal. 39:189-191
Our new double patch technique for repairing posteroinferior ventricular septal ruptures (VSRs) offers placement of patches in both the left and right ventricle, avoids ventriculotomies and gives good access and complete control of both AV-valves dur
Publikováno v:
Biochemical Pharmacology. 46:1893-1901
Cell death initiated by the adenosine analog 3-deazaadenosine (c3 Ado) was studied in human promyelocytic leukemia HL-60 cells. A rapid decrease in cell number was seen after 4-hr exposure to 50-100 microM c3 Ado. The dominating mode of cell death wa